Plettenberg / Munich / Halden, 1st March 2024 – The Prange Group and its affiliate Adragos Pharma, one of Europe’s fastest growing CDMOs, has completed the acquisition transaction of Fresenius Kabi production site in Halden, Norway – a leading sterile […]

Read about Adragos’ plans and growth predictions in Kawagoe City, Japan. Adragos aims to make significant investments in the Japanese pharmaceutical contract manufacturing industry, as reported by Nikkei. Find the complete article below! Adragos significantly invests in Japanese Kawagoe’s Plant […]

Originally published in: https://www.outsourcing-pharma.com/Article/2023/11/17/prange-group-and-adragos-pharma- to-acquire-fresenius-kabi-site We are delighted to announce that we have signed definitive agreements with Fresenius Kabi to purchase their sterile pharmaceutical production facility in Halden, Norway. This agreement is a significant milestone in Adragos’ strategic growth plans […]